Onyx has presented here at ASH and has officially announced Carfilzomib Phase IIb trials were successful. Phase III data will be available in 2010 and looks great! (Type Carfilzomib into search bar at top of page to read several posts about this exciting new myeloma drug) Here’s the catch: Even if everything goes well, that means FDA approval is still several years away. I will be attending an invitation only reception/information session about Carfilzomib this evening. Details to follow later tonight. Until then, here is the link to the Onyx press release.
Feel good, keep smiling and get some rest–I don’t have time! Pat